Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 14, 2018
[ Wed, Feb 14th 2018
] - WOPRAI
[ Wed, Feb 14th 2018
] - WOPRAI
Tue, February 13, 2018
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
Difei Yang Initiated (BOLD) at Hold and Held Target at $26 on, Feb 13th, 2018
Difei Yang of Mizuho, Initiated "Boundless Bio, Inc." (BOLD) at Hold and Held Target at $26 on, Feb 13th, 2018.
Difei has made no other calls on BOLD in the last 4 months.
There are 4 other peers that have a rating on BOLD. Out of the 4 peers that are also analyzing BOLD, 1 agrees with Difei's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, October 16th, 2017
These are the ratings of the 3 analyists that currently disagree with Difei
- Debjit Chattopadhyay of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $37 on, Wednesday, December 20th, 2017
- Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $35 on, Tuesday, December 5th, 2017
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $35 on, Tuesday, October 17th, 2017
